IV Bags, Efficiency and Resilience
U.S. hospitals are experiencing a shortage of IV bags since Hurricane Maria knocked out the major producer. Will we learn that efficiency is not terribly resilient?
U.S. hospitals are experiencing a shortage of IV bags since Hurricane Maria knocked out the major producer. Will we learn that efficiency is not terribly resilient?
Even a Convicted Murderer Can Get a Medical Marijuana Card
Families Claim the Crooked Culture of the VA Needs Revamping
OTC Drugs as Effective as Addictive Opioids for Pain Relief
Hospice Care Reliability Seems To Be Declining
Chin is Not Guilty of Murder, According to Jurors
More Arrests Made in Florida’s Sober Home Patient Brokering Investigation
What do you do if your pharmaceutical drug lacks a clear competitive advantage and is connected to a long list of side effects? If you are Bristol-Myers Squibb with its Abilify, you spend millions on consumer and physician advertising, stay silent about the drug’s risks, and trump up its benefits. This is Abilify’s story, a
Drug Companies Face Off in Dry Eye Solution Lawsuit
Purdue Pharma Not off the Hook for Everett’s Opioid Crisis